West Michigan Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-389,710
Closed -$46.8K 253
2024
Q4
$46.8K Buy
+389,710
New +$49.1K 0.01% 226
2023
Q3
Sell
-100,000
Closed -$20K 168
2023
Q2
$20K Hold
100,000
0.01% 245
2023
Q1
$21.2K Hold
100,000
0.01% 154
2022
Q4
$16.3K Buy
+100,000
New +$20.5K 0.01% 123
2022
Q3
Sell
-126,000
Closed -$28K 121
2022
Q2
$28K Buy
126,000
+42,000
+50% +$10.7K 0.02% 114
2022
Q1
$28K Buy
+84,000
New +$27.5K 0.02% 129

Other funds holding ZOM

West Michigan Advisors's ZOM Position: Q1 2025 in Review

West Michigan Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 389,710 shares — an estimated $46.8K sold.

West Michigan Advisors first reported a position in ZOM in Q1 2022 and held it in 6 quarters. The position peaked at $46.8K in Q4 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • West Michigan Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • West Michigan Advisors sold 389,710 Zomedica Corp. shares in Q1 2025, an estimated $46.8K.
  • West Michigan Advisors first reported a position in Zomedica Corp. in Q1 2022 and held it in 6 quarters.
  • West Michigan Advisors's Zomedica Corp. position peaked at $46.8K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on West Michigan Advisors's 13F filing for Q1 2025, filed 9 May 2025.